Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial

Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial

Inflammatory diseases including psoriasis are associated with metabolic and cardiovascular comorbidities, including obesity and metabolic syndrome. Obesity is associated with greater psoriasis disease severity and reduced response to treatment. Therefore, targeting metabolic comorbidities could impr...

Full description

Bibliographic Details
Main Authors: Andreas Pinter, Peter Schwarz, Sascha Gerdes, Jan C. Simon, Anja Saalbach, James Rush, Nima Melzer, Thomas Kramps, Benjamin Häberle, Maximilian Reinhardt
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Nutrients
Subjects:
psoriasis
obesity
metabolic syndrome
secukinumab
inflammation
Online Access:https://www.mdpi.com/2072-6643/13/9/3015

Internet

https://www.mdpi.com/2072-6643/13/9/3015

Similar Items